Peter Kolchinsky, PhD

Founder and Managing Partner, RA Capital Management L.P.

Dr. Peter Kolchinsky is a founder and Managing Partner of RA Capital Management L.P., a multi-stage investment manager that is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, diagnostics, services, and research tools, where he has worked since 2001. Dr. Kolchinsky has served as a member of the board of directors of ARS Pharmaceuticals Inc., a publicly traded biopharmaceutical company, since November 2022, and as a member of the board of directors of Icosavax, Inc., a publicly traded biopharmaceutical company, since July 2021, in addition to serving as a member of the board of directors of a number of privately held companies. Dr. Kolchinsky also leads RA Capital’s engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. He served on the Board of Global Science and Technology for the National Academy of Sciences from 2009 to 2012, is the author of “The Great American Drug Deal” and “The Entrepreneur’s Guide to a Biotech Startup,” and frequently writes and speaks on the future of biotechnology innovation. Dr. Kolchinsky earned his Ph.D. in virology from Harvard University and earned his bachelor’s degree in biology from Cornell University.